| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.12B | +24.1% |
| Cost of Revenue | $42.5M | +17.9% |
| Gross Profit | $352.0M | +13.7% |
| R&D Expense | $45.3M | -2.4% |
| SG&A Expense | $112.9M | +3.8% |
| Operating Income | $64.8M | +45.2% |
| Pre-tax Income | $21.0M | +156.2% |
| Income Tax | -$130.3M | -3115.8% |
| Net Income | $151.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.1M | -23.9% |
| Accounts Receivable | $110.6M | +13.1% |
| Current Assets | $229.7M | -3.7% |
| Total Assets | $855.7M | +11.5% |
| Current Liabilities | $137.5M | -42.8% |
| Long-term Debt | $387.7M | +12.7% |
| Total Liabilities | $568.9M | -13.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $73.1M | +17.4% |
| Investing Cash Flow | -$9.9M | +11.5% |
| Financing Cash Flow | -$88.7M | -57.0% |
| +462.8% |
| EPS (Basic) | $11.14 | +454.8% |
| EPS (Diluted) | $10.78 | +443.3% |
| Stockholders' Equity |
| $286.8M |
| +163.5% |